Found 4348 articles for: ""
A Case of Co-incident Phenylketonuria, Pemphigus Foliaceus, and Tinea Amiantacea Treated with Tetracycline and Nicotinamide
March 2003 | Volume 2 | Issue 2 | Case Reports | 202 | Copyright © March 2003
I report a patient with phenylketonuria who presented with pemphigus foliaceus or tinea amiantacea. The rash resolved with treatment with tetracycline and niacinamide. This article outlines the uses ...
Read MoreHypertrophic Herpes Simplex Virus in HIV Patients
March 2003 | Volume 2 | Issue 2 | Case Reports | 198 | Copyright © March 2003
Herpes simplex virus (HSV) is the most frequent sexually transmitted disease (STD) among persons seropositive for the human immunodeficiency virus (HIV)1. The typical presentations of cuta...
Read MoreAcute Pustular Psoriases Complicated by Leukocytoclastic Vasculitis
March 2003 | Volume 2 | Issue 2 | Case Reports | 193 | Copyright © March 2003
Acute pustular psoriasis is characterized by fiery-red erythema followed by formation of pustules. Precipitating factors include drugs, infections, pregnancy, solar irradiation, and psychological str...
Read MoreDiffuse Ulcerations Due to Disseminated Histoplasmosis in a Patient with HIV
March 2003 | Volume 2 | Issue 2 | Case Reports | 189 | Copyright © March 2003
Disseminated histoplasmosis is a serious disease that affects the skin, lungs, and internal organs. It is one of the diseases that characterize acquired immunodeficiency syndrome (AIDS), and in endem...
Read MoreWorsening Injection Site Reactions with Continued Use of Etanercept
March 2003 | Volume 2 | Issue 2 | Case Reports | 184 | Copyright © March 2003
We report the case of a patient with persistent and worsening injection site reactions associated with subcutaneous etanercept therapy. Injection site reactions are well documented to occur early in ...
Read MoreThe National Council on Skin Cancer Prevention: A Report
March 2003 | Volume 2 | Issue 2 | Original Article | 180 | Copyright © March 2003
Sunscreens
March 2003 | Volume 2 | Issue 2 | Original Article | 174 | Copyright © March 2003
The "Focus On:" section is designed to provide a background on one of the basic areas of our practice - A common condition, subject, or process which we as dermatologists often deal with, yet might no...
Read MoreIntralesional Use of 5-FU in Subcutaneous Fibrosis
March 2003 | Volume 2 | Issue 2 | Original Article | 169 | Copyright © March 2003
5-fluorouracil (5-FU) is an antimetabolic cytostatic drug that inhibits DNA formation. It is potentially toxic for the dysplasic epithelium, and it has therefore been used successfully as an antineopl...
Read MoreBexarotene Gel; A New Skin-Directed Treatment Option For Cutaneous T-Cell Lymphomas
March 2003 | Volume 2 | Issue 2 | Original Article | 155 | Copyright © March 2003
Cutaneous T-cell lymphomas (CTCLs) are a relatively uncommon group of lymphoproliferative disorders in which a malignant population of T cells is localized to the skin at presentation. Of the 4 class...
Read MoreA Promising New Treatment for Solar Lengtigines
March 2003 | Volume 2 | Issue 2 | Original Article | 147 | Copyright © March 2003
The purpose of this open-label study was to determine the adverse event rate of topical 4HA/tretinoin when used twice daily for up to 24 weeks with concomitant sunscreen in the treatment of solar len...
Read MoreConsact Irritant Dermatitis and Anti-Pruritic Agents: The Need to Address the Itch
March 2003 | Volume 2 | Issue 2 | Original Article | 143 | Copyright © March 2003
Contact irritant dermatitis can be defined by four interrelated elements: skin barrier disruption, epidermal skin changes, cytokine release, and nerve ending changes. The predominant symptom of eczem...
Read MoreAtopic Dermatitis : A New Treatment Paradigm Using Pimecrolimus
March 2003 | Volume 2 | Issue 2 | Original Article | 131 | Copyright © March 2003
Atopic dermatitis (AD), often called eczema, is a disease characterized by intense pruritus, erythema, dry skin, and inflammation. Pimecrolimus is a novel steroid-free treatment for AD. Consistently ...
Read MoreAntibiotic Prophylaxis for the Prevention of Endocarditis in Dermatologic Surgery: Sources of Controversy and Directions for Future Reserach
March 2003 | Volume 2 | Issue 2 | Original Article | 127 | Copyright © March 2003
Whether and when to use prophylaxis for the prevention of endocarditis has been a subject of debate among dermatologic surgeons for over 20 years. The available literature and current recommendations...
Read MoreErrata
March 2003 | Volume 2 | Issue 2 | Original Article | 124 | Copyright © March 2003
Treatment of plantar warts is often difficult and may be painful, often employing destructive treatment modalities. We report the successful treatment of a patient with a large plantar wart using Imi...
Read MoreArterial Embolization caused by Zyplast II
February 2003 | Volume 2 | Issue 1 | Case Reports | 84 | Copyright © February 2003
Arterial embolization caused by injectable preparations for soft-tissue augmentation may be less uncommon than was previously thought. This Case Report describes and explains an arterial embolization ...
Read MoreLinear Focal Elastosis: Histopathologic Diagnosis of an Uncommon Dermal Elastosis
February 2003 | Volume 2 | Issue 1 | Case Reports | 79 | Copyright © February 2003
Background: Linear focal elastosis is an uncommon dermal elastosis that occurs predominantly on the back. Although first described in the lumbar region of elderly white men, more recent reports note ...
Read MoreSuccessful Treatment of Extramammary Paget's Disease with Imiquimod
February 2003 | Volume 2 | Issue 1 | Case Reports | 73 | Copyright © February 2003
Extramammary Paget’s Disease (EMPD) is an uncommon neoplasm found in the genital, anorectal, or axillary area. Surgical excision is considered the standard treatment, although possible loss of tiss...
Read MorePlantar Wart Treatment with Combination Imiquimod and Salicylic Acid Pads
February 2003 | Volume 2 | Issue 1 | Case Reports | 70 | Copyright © February 2003
Treatment of plantar warts is often difficult and may be painful, often employing destructive treatment modalities. We report the successful treatment of a patient with a large plantar wart using Imi...
Read MoreLocal Blistering Reaction Complicating Subcutaneous Injection of Pegylated Interferon in a Patient with Hepatitis C
February 2003 | Volume 2 | Issue 1 | Case Reports | 63 | Copyright © February 2003
PEG-Intron is a covalent conjugate of recombinant alpha-2b interferon with monomethoxy polyethylene glycol (PEG). Compared to standard interferon-alpha injections, this preparation has a longer half-...
Read MoreUnregulated Alternative Medicine
February 2003 | Volume 2 | Issue 1 | Original Article | 58 | Copyright © February 2003
Unconventional (i.e. alternative, traditional, or complementary) treatments are used by many individuals for a variety of symptoms and disorders. Reports on fraudulent products used for unconventiona...
Read More
